ISSN: 2155-9899
						Ana C. Londoño
	
					    												
Colombia						                            
                            
						
 Research Article
												Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up 						
Author(s): Ana C. Londoño and Carlos A. Mora
Ana C. Londoño and Carlos A. Mora
             
						
												
				 Background: Despite the current availability of disease modifying therapies for the treatment of multiple sclerosis, there are still patients who suffer from severe neurological dysfunction in the relapsing-remitting or early progressive forms of the disease. For these patients autologous hematopoietic stem cell transplant offers an important therapeutic solution to prevent progression to irreversible disability. In spite of multiple studies in the last two decades, patient inclusion criteria, protocols for peripheral blood stem cell mobilization and bone marrow cell conditioning and methodology of follow up for autologous hematopoietic stem cell transplant in multiple sclerosis have not been strictly unified.
Methods: We reviewed five recent clinical studies that confirmed the positive outcome of transplant in spite of disclosing significant d.. View More»
				  
												DOI:
												 10.4172/2155-9899.1000455